Related Experiment Video
Updated: Aug 5, 2026
The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
Anisometropia in children: Current understanding and clinical implications
Chia-Wei Lee1,2, Yu-Chieh Yang3,4, Hsin-Yu Yang4,5,6
1Department of Ophthalmology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei, Taiwan.
Insights
Pediatric anisometropia, an eye condition in children, significantly impacts binocular vision and risks amblyopia. Early optical correction and myopia control are key to managing this refractive error and promoting healthy visual development.
Area of Science:
- Ophthalmology
- Pediatric Optometry
- Refractive Error Research
Background:
- Anisometropia in children (≥1.0D interocular difference) is a primary risk for unilateral amblyopia and disrupted binocular vision.
- It stems from asymmetric axial eye growth, disrupting normal emmetropization.
- The condition's prevalence fluctuates with age, peaking in infancy and adolescence.
Purpose of the Study:
- To review current evidence on the epidemiology, pathophysiology, associated factors, and management of pediatric anisometropia.
- To highlight the dynamic, age-related nature of anisometropia.
- To inform strategies for preventing and treating this condition.
Main Methods:
- This study is a narrative review of existing literature.
- It synthesizes data on anisometropia's prevalence, causes, and risk factors.
- It examines current and emerging management approaches.
Main Results:
- Key associated factors include genetic predisposition, visual feedback, environmental exposures, high refractive error, and near work habits.
- Hyperopic anisometropia poses a significant amblyogenic risk due to early-onset blur.
- Management involves timely optical correction and amblyopia therapy, with myopia control crucial for myopic anisometropia.
Conclusions:
- Pediatric anisometropia presents a complex clinical challenge and offers insights into refractive development.
- Prompt intervention with optical correction and amblyopia treatment is essential.
- Further longitudinal research is required to refine preventive and therapeutic strategies for optimal outcomes.
Abstract:
Anisometropia in children, defined as an interocular refractive difference of at least 1.0 diopter, is a major risk factor for unilateral amblyopia and a significant disruptor of binocular vision. The underlying structural cause is typically asymmetric axial growth, reflecting a breakdown in the normally coordinated process of emmetropization. This narrative review summarizes current evidence on its epidemiology, pathophysiology, associated factors, and management. The condition follows a dynamic age-related pattern: it is prevalent in infancy, declines during early childhood as emmetropization progresses, and rises again during school years and adolescence in parallel with increasing rates of myopia. Genetic predisposition, altered visual feedback, and environmental exposures have been implicated. Reported associated factors include high baseline refractive error, short working distance during near tasks, ocular dominance, and unilateral conditions such as congenital nasolacrimal duct obstruction. Hyperopic anisometropia is particularly amblyogenic because of its early onset and persistent blur. Management centers on prompt optical correction above amblyogenic thresholds to balance visual input, combined with amblyopia therapy when required. In myopic anisometropia, evidence-based myopia-control strategies, such as topical atropine, orthokeratology, and specialized spectacle designs, play an important role in slowing progression and reducing interocular differences. Pediatric anisometropia is both a clinical challenge and a valuable model for studying refractive development. Future longitudinal studies are needed to clarify mechanisms and optimize preventive and therapeutic strategies.
